We are live on ! Find out more
APIM

Agate Pass Investment Management Portfolio holdings

AUM $271M
1-Year Est. Return 25.12%
This Fund
S&P 500
This Quarter Est. Return
+13.66%
1 Year Est. Return
+25.12%
3 Year Est. Return
+68.04%
5 Year Est. Return
10 Year Est. Return
AUM
$271M
AUM Growth
+$15.8M
Cap. Flow
-$12.1M
Cap. Flow %
-4.45%
Top 10 Hldgs %
41.01%
Holding
113
New
8
Increased
16
Reduced
66
Closed
4

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.74M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.92M
3
VUG icon
Vanguard Growth ETF
VUG
+$1.45M
4
AAPL icon
Apple
AAPL
+$1.01M
5
DIS icon
Walt Disney
DIS
+$840K

Sector Composition

Rank Sector Weight
1 Technology 17.66%
2 Healthcare 12.22%
3 Financials 10.22%
4 Communication Services 7.51%
5 Consumer Discretionary 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
101
Nike
NKE
$60.8B
$227K 0.08%
5,522
-7,303
-57% -$321K
IJR icon
102
iShares Core S&P Small-Cap ETF
IJR
$109B
$226K 0.08%
+1,521
New +$209K
BALL icon
103
Ball Corp
BALL
$16.6B
$222K 0.08%
3,560
HD icon
104
Home Depot
HD
$324B
$219K 0.08%
620
FISV
105
Fiserv Inc
FISV
$26.6B
$219K 0.08%
4,457
-737
-14% -$41.2K
VOT icon
106
Vanguard Mid-Cap Growth ETF
VOT
$19.2B
$217K 0.08%
+709
New +$205K
VCR icon
107
Vanguard Consumer Discretionary ETF
VCR
$5.81B
$209K 0.08%
528
-133
-20% -$51.7K
VYM icon
108
Vanguard High Dividend Yield ETF
VYM
$80.6B
$205K 0.08%
1,296
-384
-23% -$60K
BMY icon
109
Bristol-Myers Squibb
BMY
$126B
$202K 0.07%
3,500
LHX icon
110
L3Harris
LHX
$55.8B
-610
Closed -$211K
MCD icon
111
McDonald's
MCD
$187B
-731
Closed -$227K
NVO
112
Novo Nordisk
NVO
$213B
-7,984
Closed -$293K
RMD icon
113
ResMed
RMD
$27.8B
-1,011
Closed -$227K

Similar funds

Agate Pass Investment Management's Q2 2026 Portfolio in Review

As of Q2 2026, Agate Pass Investment Management held 113 positions worth $271M, up 6.2% from $255M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Agate Pass Investment Management withdrew a net $12.1M in Q2 2026, closing 4 positions and reducing 66 holdings. Its most notable exit was Novo Nordisk, an estimated $293K position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Agate Pass Investment Management opened a new position in Schwab US Large-Cap Growth ETF worth $302K.

  • Agate Pass Investment Management's largest Q2 2026 buy was Schwab US Large-Cap Growth ETF: 8,925 shares worth $302K.
  • Agate Pass Investment Management added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2026, an estimated $1.54M increase.
  • Agate Pass Investment Management's biggest Q2 2026 reduction was AbbVie, cutting an estimated $2.74M.
  • Agate Pass Investment Management fully exited Novo Nordisk in Q2 2026, selling an estimated $293K.
  • Agate Pass Investment Management's ten largest holdings make up 41% of its $271M portfolio in Q2 2026.
  • Agate Pass Investment Management opened 8 new positions and closed 4 in Q2 2026.
  • Agate Pass Investment Management's portfolio value rose 6.2% quarter-over-quarter to $271M.

Based on Agate Pass Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.